[ad_1] Osiris Therapeutics (ASX: OSIR) ANALYSIS OF FOCUS PERFORMANCE: PROFITABILITY REPORT: Monitoring of the control of profitability, the profit margin of the company recorded at 4.66% and the operating margin recorded at 3.14%. The company maintained a gross margin of 63.78%. The corporate ownership of the company is 48.27% while …
Read More »OSIR) – Bitcoin & Stock Journal
